What is the recommended dose of midazolam (benzodiazepine) for a 7-month-old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam Dosing for a 7-Month-Old Infant

For a 7-month-old infant, the recommended midazolam dose for sedation/anxiolysis is 0.05-0.10 mg/kg intravenously given over 2-3 minutes (maximum single dose: 5 mg). 1

Route-Specific Dosing Recommendations

Intravenous (IV) Administration

  • For sedation/anxiolysis: 0.05-0.10 mg/kg given over 2-3 minutes 1
  • Peak effect occurs at 3-5 minutes after administration 1
  • Dose, observe, and redose every 3-5 minutes as needed to avoid oversedation 1
  • For adjunct to endotracheal intubation: 0.2 mg/kg (allow 2-3 minutes for effect before administering muscle relaxant) 1
  • For continuous infusion in intubated patients: Start with 0.05-0.2 mg/kg loading dose over 2-3 minutes, followed by 1 μg/kg/minute (0.06 mg/kg/hour) 2, 3

Oral (PO) Administration

  • 0.25-0.50 mg/kg (maximum: 20 mg) 1
  • Children under 6 years old may require up to 1 mg/kg 1

Intramuscular (IM) Administration

  • For seizures: 0.2 mg/kg (maximum: 6 mg per dose); may repeat every 10-15 minutes 1
  • For sedation: 0.1 to 0.15 mg/kg is usually effective 3

Monitoring and Safety Considerations

  • Increased risk of apnea when combined with other sedative agents, particularly opioids 1, 2
  • Always be prepared to provide respiratory support regardless of administration route 1
  • Continuous monitoring of oxygen saturation is essential 2
  • Monitor for hypotension, particularly when administered rapidly 2, 4
  • Paradoxical agitation may occur, especially in younger children 1

Special Considerations for Infants

  • Limited information is available for non-intubated infants less than 6 months of age 3
  • Infants are particularly vulnerable to airway obstruction and hypoventilation; therefore, titration with small increments to clinical effect and careful monitoring are essential 3
  • Midazolam has a longer half-life in neonates (12 hours) compared to older children (0.8-1.8 hours) 5, 4
  • Administer cautiously to infants, particularly if fentanyl is also given, due to increased risk of hypotension 4

Antidote Information

  • Flumazenil may be administered to reverse life-threatening respiratory depression caused by midazolam 1, 2
  • Be aware that flumazenil will also reverse the anticonvulsant effects and may precipitate seizures if midazolam was used for seizure control 1

Practical Administration Tips

  • Titrate slowly to the desired clinical effect 3
  • For IV administration, the initial dose should be given over 2-3 minutes 3
  • Wait an additional 2-3 minutes to fully evaluate the sedative effect before initiating a procedure or repeating a dose 3
  • If other CNS depressants are coadministered, the dose of midazolam should be adjusted accordingly 3

Remember that the effectiveness of midazolam is high (97.8% in dental procedures), but careful dosing and monitoring are essential to minimize adverse effects 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midazolam Infusion Dosing for Ventilated 1-Month-Old Child

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.